Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven V Edelman

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|September 5, 2015
BIOSIMILARS AND NEW INSULIN VERSIONSAnne L Peters, R Daniel Pollom, Jason S Zielonka, et al.
The Diabetes Educator|August 24, 2010
Are patients' initial experiences at the diagnosis of type 2 diabetes associated with attitudes and self-management over time?William H Polonsky, Lawrence Fisher, Susan Guzman, et al.
Current Medical Research and Opinion|June 4, 2014
Testing versus guessing blood glucose values: impact on self-care behaviors in type 2 diabetesJeremy Pettus, Patricia Stenger, Holly C Schachner, et al.
Journal of Diabetes Science and Technology|September 2, 2011
A 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injectionsJuan P Frias, Bruce W Bode, Timothy S Bailey, et al.
Diabetes Care|August 13, 2017
Understanding the Gap Between Efficacy in Randomized Controlled Trials and Effectiveness in Real-World Use of GLP-1 RA and DPP-4 Therapies in Patients With Type 2 DiabetesGinger S Carls, Edward Tuttle, Ruo-Ding Tan, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2004
Skeletal muscle GLUT1 transporter protein expression and basal leg glucose uptake are reduced in type 2 diabetesTheodore P Ciaraldi, Sunder Mudaliar, Ario Barzin, et al.
The Patient|December 17, 2016
Development and Content Validity of the Statin Experience Assessment Questionnaire (SEAQ)©Terry A Jacobson, Steven V Edelman, Nina Galipeau, et al.
Diabetes Technology & Therapeutics|July 10, 2010
Insulin pump therapy in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimenSteven V Edelman, Bruce W Bode, Timothy S Bailey, et al.
Postgraduate Medicine|June 11, 2013
Pramlintide improved measures of glycemic control and body weight in patients with type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion therapyKathrin Herrmann, Juan P Frias, Steven V Edelman, et al.
Journal of Diabetes Science and Technology|November 6, 2009
Significant insulin dose errors may occur if blood glucose results are obtained from miscoded metersCharles H Raine, Linda E Schrock, Steven V Edelman, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|September 5, 2015
BIOSIMILARS AND NEW INSULIN VERSIONSAnne L Peters, R Daniel Pollom, Jason S Zielonka, et al.
The Diabetes Educator|August 24, 2010
Are patients' initial experiences at the diagnosis of type 2 diabetes associated with attitudes and self-management over time?William H Polonsky, Lawrence Fisher, Susan Guzman, et al.
Current Medical Research and Opinion|June 4, 2014
Testing versus guessing blood glucose values: impact on self-care behaviors in type 2 diabetesJeremy Pettus, Patricia Stenger, Holly C Schachner, et al.
Journal of Diabetes Science and Technology|September 2, 2011
A 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injectionsJuan P Frias, Bruce W Bode, Timothy S Bailey, et al.
Diabetes Care|August 13, 2017
Understanding the Gap Between Efficacy in Randomized Controlled Trials and Effectiveness in Real-World Use of GLP-1 RA and DPP-4 Therapies in Patients With Type 2 DiabetesGinger S Carls, Edward Tuttle, Ruo-Ding Tan, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2004
Skeletal muscle GLUT1 transporter protein expression and basal leg glucose uptake are reduced in type 2 diabetesTheodore P Ciaraldi, Sunder Mudaliar, Ario Barzin, et al.
The Patient|December 17, 2016
Development and Content Validity of the Statin Experience Assessment Questionnaire (SEAQ)©Terry A Jacobson, Steven V Edelman, Nina Galipeau, et al.
Diabetes Technology & Therapeutics|July 10, 2010
Insulin pump therapy in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimenSteven V Edelman, Bruce W Bode, Timothy S Bailey, et al.
Postgraduate Medicine|June 11, 2013
Pramlintide improved measures of glycemic control and body weight in patients with type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion therapyKathrin Herrmann, Juan P Frias, Steven V Edelman, et al.
Journal of Diabetes Science and Technology|November 6, 2009
Significant insulin dose errors may occur if blood glucose results are obtained from miscoded metersCharles H Raine, Linda E Schrock, Steven V Edelman, et al.
Pageof 9